Latest Breaking News On - Company on twitter cannabics - Page 8 : comparemela.com

Study design and results: Both the experimental and the control groups were inoculated with human colorectal cancer cells. Daily doses of intraperitoneal (IP) delivery of RCC-33 or sham control were initiated on day 5. Differences in tumor volume between the two groups were first observed after 5 days of treatment (day 10). Previously published interim results showing a 27% reduction in tumor volume were recorded after 12 days of treatment (day 17), with p value ≤ 0.022. The study was concluded after 16 days of treatment (day 21) when a member of the control group reached a predetermined tumor size. Final results recorded a significant and robust 33% reduction in tumor volume in RCC-33 treated mice in comparison with the control group, p value ≤0.016.

United statesGabriel yarivFacebook cannabicspharmaceuticalsInstagram cannabicsEyal baradExchange commissionCompany on twitter cannabicsCannabics pharmaceuticalsPrnewswire cannabics pharmaceuticals incMinistry of healthCannabics pharmaceuticals incCannabics pharmaceutical co founderCannabics pharmaceutical presidentPrivate securities litigation reform actHealth care amp hospitalsSmall cap